What's new? In recent years, the possible prognostic impact of concomitant medications in patients with cancer treated with immunotherapy combinations has generated increasing interest. This real‐world analysis evaluated the impact of concomitant medications on survival outcomes in patients with advanced biliary tract cancer treated with cisplatin ...
Federica Lo Prinzi+71 more
wiley +1 more source
Immunosuppressive therapy and tolerance of organ allografts [PDF]
Starzl, TE
core +1 more source
Covered Self-Expanding Metal Stents Versus Multiple Plastic Stents in Treating Biliary Strictures Post-Orthotopic Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Rocha Fernandes Y+9 more
europepmc +1 more source
Urinary tract endometriosis: Revisiting the definition of ureterolysis
Abstract Objectives To report the incidence of urinary tract endometriosis (UTE) among patients with deep endometriosis, and to analyze surgical procedures, the rate of complications, and the recurrence rate in patients with UTE managed in a French expert center.
Constance Durant Des Aulnois+9 more
wiley +1 more source
A prospective analysis of ureteral stenting during radical cystectomy and ileal conduit urinary diversion: Paediatric feeding tubes versus single-J stents. [PDF]
Ryan JT+8 more
europepmc +1 more source
Enhancing thromboresistance of neurovascular nickel-titanium devices with responsive heparin hydrogel coatings. [PDF]
Maitz MF+6 more
europepmc +1 more source
ABSTRACT Introduction Bladder cancer in patients with ureteral anomalies presents unique surgical challenges, particularly regarding urinary diversion. This case highlights a novel approach to uretero‐ileal anastomosis in a patient with duplicated right ureters undergoing radical cystectomy.
Kyotaro Fukuta+8 more
wiley +1 more source
Difference between magnetic versus conventional ureteral stents in morbidity and efficiency after double J stents removal: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Adhyatma KP+4 more
europepmc +1 more source